Leukemia Home > Gleevec and Other Uses

Gleevec® (imatinib mesylate) is licensed to treat certain types of cancer, such as leukemia and GIST. It belongs to a group of chemotherapy medications called tyrosine kinase inhibitors, which means it blocks an enzyme that cancer cells need to grow. Other uses for Gleevec include the treatment of:
  • Myelodysplastic syndrome (MDS) and myeloproliferative disease (MPD)
  • Hypereosinophilic syndrome (HES) or chronic eosinophilic leukemia
  • Aggressive systemic mastocytosis (ASM)
  • Dermatofibrosarcoma protuberans (DFSP).
(Click Gleevec Uses for information on the other conditions this drug can treat, when it is prescribed, whether children can take it, and more.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.